Radiopharmaceuticals for PET and SPECT imaging: a literature review over the last decade
G Crișan, NS Moldovean-Cioroianu… - International journal of …, 2022 - mdpi.com
Positron emission tomography (PET) uses radioactive tracers and enables the functional
imaging of several metabolic processes, blood flow measurements, regional chemical …
imaging of several metabolic processes, blood flow measurements, regional chemical …
Clinical quantitative coronary artery stenosis and coronary atherosclerosis imaging: a Consensus Statement from the Quantitative Cardiovascular Imaging Study …
AJV Mézquita, F Biavati, V Falk, H Alkadhi… - Nature Reviews …, 2023 - nature.com
The detection and characterization of coronary artery stenosis and atherosclerosis using
imaging tools are key for clinical decision-making in patients with known or suspected …
imaging tools are key for clinical decision-making in patients with known or suspected …
PET/MR imaging of inflammation in atherosclerosis
Myocardial infarction, stroke, mental disorders, neurodegenerative processes, autoimmune
diseases, cancer and the human immunodeficiency virus impact the haematopoietic system …
diseases, cancer and the human immunodeficiency virus impact the haematopoietic system …
Imaging inflammation with positron emission tomography
J Iking, M Staniszewska, L Kessler, JM Klose… - Biomedicines, 2021 - mdpi.com
The impact of inflammation on the outcome of many medical conditions such as
cardiovascular diseases, neurological disorders, infections, cancer, and autoimmune …
cardiovascular diseases, neurological disorders, infections, cancer, and autoimmune …
In vivo targeting of CXCR4—new horizons
M Schottelius, K Herrmann, C Lapa - Cancers, 2021 - mdpi.com
Simple Summary Beyond its pre-eminent role in the context of tumor cell growth as well as
metastasis, the CXC motif chemokine receptor 4 (CXCR4) is a key player in the …
metastasis, the CXC motif chemokine receptor 4 (CXCR4) is a key player in the …
[HTML][HTML] A new class of PentixaFor-and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency
T Osl, A Schmidt, M Schwaiger, M Schottelius… - Theranostics, 2020 - ncbi.nlm.nih.gov
Non-invasive PET imaging of CXCR4 expression in cancer and inflammation as well as
CXCR4-targeted radioligand therapy (RLT) have recently found their way into clinical …
CXCR4-targeted radioligand therapy (RLT) have recently found their way into clinical …
CXCR4-directed imaging in solid tumors
Despite histological evidence in various solid tumor entities, available experience with
CXCR4-directed diagnostics and endoradiotherapy mainly focuses on hematologic …
CXCR4-directed diagnostics and endoradiotherapy mainly focuses on hematologic …
[HTML][HTML] Targeting the chemokine network in atherosclerosis
Chemokines and their receptors represent a potential target for immunotherapy in chronic
inflammation. They comprise a large family of cytokines with chemotactic activity, and their …
inflammation. They comprise a large family of cytokines with chemotactic activity, and their …
Imaging inflammation in atherosclerosis with CXCR4-directed 68Ga-pentixafor PET/CT: correlation with 18F-FDG PET/CT
M Kircher, J Tran-Gia, L Kemmer, X Zhang… - Journal of Nuclear …, 2020 - Soc Nuclear Med
CXC motif chemokine receptor 4 (CXCR4) is expressed on the surface of various cell types
involved in atherosclerosis, with a particularly rich receptor expression on macrophages and …
involved in atherosclerosis, with a particularly rich receptor expression on macrophages and …
[68Ga]Pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid artery
X Li, W Yu, T Wollenweber, X Lu, Y Wei… - European Journal of …, 2019 - Springer
Purpose Type 4 chemokine receptor (CXCR4) plays an important role in immune cell
migration during the atherosclerosis progression. We aimed to evaluate [68 Ga] Pentixafor …
migration during the atherosclerosis progression. We aimed to evaluate [68 Ga] Pentixafor …